-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
June 01, 2022 - Results from included studies: KQ 2. nonsteroidal anti-inflammatory drugs ............ … Rimegepant 75 mg is more effective for migraine
than nonsteroidal anti-inflammatory drugs: post
hoc … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … CNS Drugs. 2020
Oct;34(10):1015-24. doi: 10.1007/s40263-020-
00753-1. PMID: 32857291.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
June 01, 2022 - Results from included studies: KQ 2. nonsteroidal anti-inflammatory drugs ............ … Rimegepant 75 mg is more effective for migraine
than nonsteroidal anti-inflammatory drugs: post
hoc … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … CNS Drugs. 2020
Oct;34(10):1015-24. doi: 10.1007/s40263-020-
00753-1. PMID: 32857291.
-
effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere
Good check for publication bias
Regulatory Web sites:
Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008.
Sassi F, Archard L, McDaid D.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/searching.ppt
January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere
Good check for publication bias
Regulatory Web sites:
Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008.
Sassi F, Archard L, McDaid D.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Galt.pdf
April 23, 2004 - Giveaway drugs: good intentions, bad
design. Health Affairs, 2004;23(1):213–17.
25.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Galt.pdf
April 23, 2004 - Giveaway drugs: good intentions, bad
design. Health Affairs, 2004;23(1):213–17.
25.
-
meps.ahrq.gov/data_files/publications/st377/stat377.pdf
July 01, 2012 - Statistical Brief #377: Trends in Use and Expenditures for Depression among U.S. Adults Age 18 and Older, Civilian Noninstitutionalized Population, 1999 and 2009
STATISTICAL BRIEF #377
July 2012
Trends in Use and Expenditures for Depression among U.S. Adults Age 18 and
Older, Civilian Noninstitutionalized Populatio…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - and other psychotic symptoms
associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
-
www.ahrq.gov/news/newsletters/e-newsletter/625.html
July 01, 2018 - Hispanics, and people living in the South or without health insurance were less likely to take the drugs
-
www.ahrq.gov/news/newsletters/e-newsletter/624.html
July 01, 2018 - Drugs Aging 2017 Mar;34(3):191-201. Access the abstract on PubMed®.
-
srdr.ahrq.gov/projects/1565/studies/189585
January 01, 2017 - Patients with a regular alcohol intake and/or use of psychoactive drugs
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
July 19, 2009 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-effectiveness-of-interventions-designed-to-support-children-in-transition-from-pediatric-care-to-adult-care-with-special-health-care-needs-ineffective-transition-planning-can-have-significant-negative-consequences
January 07, 2013 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to